Cholesterol-ferroptosis nexus: Unveiling novel cancer therapeutic avenues

Jaewang Lee1, Jong-Lyel Roh1

  • 1Department of Otorhinolaryngology-Head and Neck Surgery, CHA Bundang Medical Center, CHA University, Seongnam, Republic of Korea; Department of Biomedical Science, General Graduate School, CHA University, Pocheon, Republic of Korea.

Cancer Letters
|June 9, 2024
PubMed

Insights

Ferroptosis, a cell death process involving iron and lipid peroxidation, can be targeted by modulating cholesterol metabolism. Inhibiting cholesterol synthesis offers a novel therapeutic strategy for cancer treatment.

Area of Science:

  • Biochemistry
  • Oncology
  • Cell Biology

Background:

  • Ferroptosis is a regulated cell death pathway driven by iron-dependent lipid peroxidation.
  • This process is implicated in tumor progression and resistance to cancer therapies.
  • Cholesterol metabolism pathways are increasingly recognized for their role in cancer cell survival and death.

Purpose of the Study:

  • To review the relationship between ferroptosis and cholesterol metabolism, focusing on the biosynthesis pathway.
  • To explore therapeutic strategies targeting cholesterol metabolism for inducing ferroptosis in cancer.
  • To provide insights into novel approaches for modulating ferroptosis and associated diseases.

Main Methods:

  • Literature review focusing on ferroptosis and cholesterol metabolism.
  • Analysis of mechanisms linking lipid peroxidation and cholesterol biosynthesis.
  • Examination of therapeutic targets within cholesterol pathways.

Main Results:

  • Cholesterol biosynthesis pathways significantly influence ferroptosis.
  • Inhibiting key enzymes like HMG-CoA reductase can induce ferroptosis.
  • Targeting the 7-dehydrocholesterol pathway offers new ways to control ferroptosis.

Conclusions:

  • Modulating cholesterol metabolism presents a promising therapeutic avenue for cancer.
  • Targeting lipid metabolism, particularly cholesterol pathways, can induce ferroptosis in cancer cells.
  • Understanding ferroptosis-cholesterol interplay is crucial for developing innovative cancer treatments.

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Molecular Chaperones and Protein Folding03:00

Molecular Chaperones and Protein Folding

The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
17.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
8.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K